Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Endomagnetics in £2.1m Fund Raising

Published: Monday, August 12, 2013
Last Updated: Monday, August 12, 2013
Bookmark and Share
The funds will be used to expand the Endomagnetics team and provide additional resource to develop the company’s business in overseas markets.

All the existing investors took part in the latest Series B round: New Wave Ventures, Sarum Capital, UCL Business and Sussex Place Ventures. This brings the total raised by the Company to date to £4.6 million ($7m US).

Endomagnetics has been ramping up sales through Sysmex, its recently appointed distributor for the EMEA region, and new partnerships are being created with hospitals and clinics looking to adopt a more efficient and effective method for sentinel lymph node localisation - a key procedure in breast cancer diagnosis and treatment. Endomagnetics’ SentiMag® system uses advanced sensing technology to detect the location of injected Sienna+® tracer material, eliminating the need for the short-life radioactive alternatives in use today.

“We are delighted that all our investors have demonstrated their continued support for the business through this further fund raising”, said CEO of Endomagnetics Dr Eric Mayes. “Reaction of clinicians to our SentiMag® product has been most enthusiastic.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More Than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Endomagnetics Announces Quality Certification and COO Appointment
Endomagnetics has achieved certification to an international quality standard.
Tuesday, October 02, 2012
Endomagnetics Awarded Funding to Explore Melanoma Detection
The project will explore the clinical feasibility of applying magnetic sentinel lymph node (SLN) detection to melanoma.
Friday, August 03, 2012
Endomagnetics Strengthens its Operations
Two Key Appointments made as technology company expands
Tuesday, November 22, 2011
Endomagnetics Raises Additional Funding and Opens Cambridge Office
Company to expands its operations and move to Cambridge.
Monday, November 14, 2011
Scientific News
Open Source Seed Initiative – A Welcome Boost to Global Crop Breeding
A team of plant breeders, farmers, non-profit agencies, seed advocates, and policymakers have created the Open Source Seed Initiative.
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
A New Way Out for Stem Cells
Researchers at North Carolina State University have discovered that therapeutic stem cells exit the bloodstream in a different manner than was previously thought.
One Giant Leap for the Future of Safe Drug Delivery
Sheffield engineers make major breakthrough in developing silk ‘micro-rockets’ that can be used safely in biological environments.
Designing Potential AIDS Vaccine Candidates
Findings represent ‘big accomplishment’ in biomedical engineering and design.
Anticancer Drug Stops Ebola Virus Molecule in its Tracks
A team of scientists from the University of Oxford have successfully mapped the structure of the Ebola virus molecule that drives the attack strategy and leads to fatal infections in humans.
Assessing the Effectiveness of Genome-Editing Technologies
Researchers have developed a cost-effective and rapid method for assessing edits generated by CRISPR-Cas9 and other genome-editing technologies.
Anthrax Proteins Might Help Treat Cancerous Tumors
Studies in mice reveal novel treatment regimen.
New Cancer Drug Target Found in Dual-Function Protein
Findings from a study from TSRI have shown that targeting a protein called GlyRS might help to halt cancer growth.
Key to Chronic Fatigue Syndrome is in Your Gut, Not Head
Researchers report they have identified biological markers of the disease in gut bacteria and inflammatory microbial agents in the blood.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!